The delisting risk removal is a positive catalyst that may support the stock in the near term, but the company's fundamental cash runway remains very short ($3.3M as of year-end 2025) and it still faces a going-concern risk. Monitor for any capital raise or clinical data updates that would address the cash position.
Price Chart
Executive Summary
Apollomics Inc. regained compliance with Nasdaq's minimum Market Value of Listed Securities (MVLS) requirement, resolving a delisting risk that was flagged on June 18, 2026. The company demonstrated MVLS of $35 million or greater for 10 consecutive business days from June 23 to July 7, 2026, and the matter is now closed. This removes a near-term overhang but does not address the company's fundamental cash runway or clinical development challenges.
Key Facts
- Received written notice from Nasdaq on July 8, 2026 confirming regained compliance with MVLS requirement (Rule 5550(b)(2)).
- Had been non-compliant since June 18, 2026 for failing to maintain minimum MVLS of $35 million over 30 consecutive business days.
- Demonstrated MVLS of $35 million or greater for 10 consecutive business days from June 23, 2026 to July 7, 2026.
- The delisting matter is now closed.
Financial Impact
Removes immediate delisting risk, which was a material overhang given the company's $31M market cap and precarious cash position ($3.3M cash as of year-end 2025 per cross-filing).
Risk Factors
- Cash position of only $3.3M as of year-end 2025 is insufficient to fund operations through April 2027.
- Lead drug vebreltinib faces development delays and patent risks.
- Ongoing litigation with Medpace and a $5.0M settlement obligation strain finances.
- Substantial doubt about ability to continue as a going concern remains.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-302494 |
| Document: d31896dex991.htm | 0001193125-26-302494 |
| Document: 0001193125-26-302494-index-headers.html | 0001193125-26-302494 |
| Document: 0001193125-26-302494-index.html | 0001193125-26-302494 |
| Document: 0001193125-26-302494.txt | 0001193125-26-302494 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 10w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $19.90 (−16.81%) |
Aug 17, 2026 10w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $19.90 (−16.81%) |
Aug 17, 2026 10w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $19.90 (−16.81%) |
Aug 17, 2026 10w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $19.90 (−16.81%) |
Jul 21, 2026 13w ago | 6-K | $18.71 $18.00 | ▼ −3.77% | ▼ −2.54% | $19.90 (+6.39%) |
Jul 14, 2026 14w ago | 6-K | $15.70 $18.86 | ▲ +20.13% | ▲ +21.42% | $19.90 (+26.75%) |
Jun 24, 2026 17w ago | 6-K | $22.00 $20.16 | ▲ +8.36% | ▲ +9.92% | $19.90 (+9.55%) |
Apr 27, 2026 26w ago | Press Release | $13.19 $16.47 | ▲ +24.84% | ▲ +24.44% | $19.90 (+50.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers